Bottom line
Is PSLAX a good fund? The bottom line
PSLAX is the Class A share class of Putnam Small Cap Value Fund, a managed small-cap mutual fund from Franklin Templeton.
Annual fees run 1.1% — about $110 a year on every $10,000 invested, more expensive than 60% of small-cap funds we track.
It returned −0.8% over one year, +9.5% a year over five years, +8.3% a year over ten (as of Dec 31, 2025, per its prospectus).
With $297 million in net assets and 128 holdings, its largest position is Putnam Cash Collateral Pool LLC (17.5%) and the top 10 make up 30.2% of the portfolio.
This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.
What stands out
- 5-year return beat 77% of category peers
What to watch
- Front-end sales load up to 5.75%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What PSLAX invests in
The fund seeks capital appreciation.
The fund invests mainly in common stocks of small U.S. companies, with a focus on value stocks. Under normal circumstances, the fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in equity securities of value companies of a size similar to those in the Russell 2000 Index over the past six months. This policy may be changed only after 60 days notice to shareholders. As of April 30, 2026, the index was composed of companies having market capitalizations of between approximately $18.3 million and $80.5 billion. The Investment Manager, as defined below, considers an issuer to be a value company if (i) the issuer is included in an index which is representative of value companies, (ii) the issuer is classified as a value company by an independent third party, and/or (iii) the Investment Manager believes the issuer is currently undervalued…
From the fund's prospectus (filed Jun 23, 2026).
PSLAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| PSLAX | −0.8% | +9.5% | +8.3% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What PSLAX costs
On a $10,000 investment, PSLAX's 1.1% expense ratio costs about $110 a year. The prospectus estimates $1,839 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
PSLAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Putnam Cash Collateral Pool LLC | 17.51% |
| 2 | Vishay Intertechnology, Inc. | 1.74% |
| 3 | Veracyte, Inc. | 1.61% |
| 4 | Cohu, Inc. | 1.58% |
| 5 | BrightSpring Health Services, Inc. | 1.45% |
| 6 | LifeStance Health Group, Inc. | 1.41% |
| 7 | IBEX Holdings Ltd. | 1.29% |
| 8 | Bel Fuse, Inc. | 1.25% |
| 9 | Five Star Bancorp | 1.19% |
| 10 | Nicolet Bankshares, Inc. | 1.19% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 30.2% of the fund. See all top 25 holdings and asset mix →